Stay informed with the latest litigation news. Explore now

IP Verse

Nuvamid competitive analysis

Latest publications and patents of Nuvamid New

Explore the latest publications and patents granted to Nuvamid, showcasing their recent innovations and technological advancements.

Last updated on: Sep 6, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Nuvamid

EP4084799
Apr 17, 2024Use Of Nmn For The Prevention And/Or Treatment Of Joint Pain Induced By Physical Activity, And Corresponding CompositionsGranted And Under Opposition
EP4196127
Jan 31, 2024Nicotinamide Mononucleotide Derivatives And Use Thereof In The Treatment And Prevention Of A Red Blood Cell DisorderGranted And Under Opposition
EP4028021
Jan 24, 2024Use Of Nmn For The Prevention And/Or Treatment Of Pain, And Corresponding CompositionsGranted And Under Opposition

Latest patents of Nuvamid opposed by its competitors

Explore Nuvamid's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4084799
Apr 17, 2024Use Of Nmn For The Prevention And/Or Treatment Of Joint Pain Induced By Physical Activity, And Corresponding Compositions1
EP4196127
Jan 31, 2024Nicotinamide Mononucleotide Derivatives And Use Thereof In The Treatment And Prevention Of A Red Blood Cell Disorder1
EP4028021
Jan 24, 2024Use Of Nmn For The Prevention And/Or Treatment Of Pain, And Corresponding Compositions1

Latest PTAB cases involving Nuvamid New

Discover the latest PTAB cases involving Nuvamid, highlighting their recent legal challenges and patent disputes.

Top competitors of Nuvamid

Top competitors of Nuvamid based on patent oppositions.